Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Visucomplex Plus is a multicomponent nutraceutical formulation developed by Visufarma specifically for the management of ocular vascular disorders and the preservation of retinal health. The product combines three anthocyanin-rich botanical extracts—bilberry (*Vaccinium myrtillus*), black chokeberry (*Aronia melanocarpa*), and haskap berry (*Lonicera caerulea*)—with the flavonoid rutin and a B-vitamin complex (B6, B12, and folic acid). The anthocyanins and rutin provide potent antioxidant activity and vasoprotective effects, helping to stabilize capillary permeability and improve microcirculation in the eye by protecting vascular endothelial cells and inhibiting aldose reductase. The inclusion of vitamins B6, B12, and folic acid targets the homocysteine metabolic pathway; elevated homocysteine is a recognized risk factor for vascular damage in conditions such as age-related macular degeneration (AMD) and diabetic retinopathy. By reducing oxidative stress and regulating homocysteine levels, Visucomplex Plus provides neuroprotection and vascular support to the visual system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Visucomplex Plus.